AIP
NAUT icon

Ameritas Investment Partners’s Nautilus Biotechnolgy NAUT Stock Holding History

Ameritas Investment Partners’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,575
Closed -$3.08K – 3289
2025
Q1 		$3.08K Hold
3,575
– – ﹤0.01% 3042
2024
Q4 		$6.01K Hold
3,575
– – ﹤0.01% 3007
2024
Q3 		$10.2K Hold
3,575
– – ﹤0.01% 2912
2024
Q2 		$8.37K Hold
3,575
– – ﹤0.01% 2975
2024
Q1 		$10.5K Hold
3,575
– – ﹤0.01% 2802
2023
Q4 		$10.7K Hold
3,575
– – ﹤0.01% 2827
2023
Q3 		$11.3K Hold
3,575
– – ﹤0.01% 2791
2023
Q2 		$13.8K Hold
3,575
– – ﹤0.01% 2763
2023
Q1 		$9.9K Hold
3,575
– – ﹤0.01% 2728
2022
Q4 		$6.58K Hold
3,575
– – ﹤0.01% 2887
2022
Q3 		$7K Hold
3,575
– – ﹤0.01% 2878
2022
Q2 		$9K Buy
+3,575
New +$13.3K ﹤0.01% 2861

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Ameritas Investment Partners's NAUT Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 3,575 shares — an estimated $3.08K sold.

Ameritas Investment Partners first reported a position in NAUT in Q2 2022 and held it in 12 quarters. The position peaked at $13.8K in Q2 2023. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,575 Nautilus Biotechnolgy shares in Q2 2025, an estimated $3.08K.
  • Ameritas Investment Partners first reported a position in Nautilus Biotechnolgy in Q2 2022 and held it in 12 quarters.
  • Ameritas Investment Partners's Nautilus Biotechnolgy position peaked at $13.8K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.